MAUDE Adverse Event Report: NOBEL BIOCARE AB NOBELZYGOMA 0° 50MM; ENDOSSEOUS DENTAL IMPLANT

Model Number	38282
Medical Device Problem Code	Fracture (1260)
Health Effect - Clinical Code	Failure of Implant (1924)
Date of Event	02/23/2022
Type of Reportable Event	Serious Injury
Event or Problem Description
The implant malfunctioned due to it fracturing during placement.The malfunction did not cause or contribute to a death or serious injury.

• Brand Name: NOBELZYGOMA 0° 50MM
• Common Device Name: ENDOSSEOUS DENTAL IMPLANT
• Manufacturer (Section D): NOBEL BIOCARE AB; dimbovägen 2; karlskoga 69151 ; SW 69151
• MDR Report Key: 13695661
• Report Number: 2027971-2022-048420
• Device Sequence Number: 11738705
• Product Code: DZE
• UDI-Device Identifier: 07332747161533
• UDI-Public: (01)07332747161533(10)12163750(17)251012
• Combination Product (Y/N): N
• Initial Reporter Country: GM
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2022
• Device Explanted Year: 2022
• Serviced by Third Party (Y/N): N
• Reporter Type: Importer
• Initial Reporter Occupation: Dentist
• Type of Report: Initial
• Report Date (Section F): 03/08/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 10/12/2025
• Device Model Number: 38282
• Device Catalogue Number: 38282
• Device Lot Number: 12163750
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Date Returned to Manufacturer: 03/02/2022
• Is the Reporter a Health Professional?: Yes
• Was the Report Sent to FDA?: No
• Distributor Facility Aware Date: 02/25/2022
• Event Location: Outpatient Treatment Facility
• Initial Date Received by Manufacturer: Not provided
• Initial Report FDA Received Date: 03/08/2022
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: A
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 52 YR
• Patient Sex: Male
• Date Report Sent to FDA: 03/08/2022